End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- CHF | -.--% | -.--% | -.--% |
07-01 | Nu Skin Enterprises, Inc.(NYSE:NUS) added to Russell 2000 Dynamic Index | CI |
05-09 | DA Davidson Adjusts Nu Skin Enterprises' Price Target to $12.50 From $15.50, Keeps Neutral Rating | MT |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- With a P/E ratio at 12.08 for the current year and 7.69 for next year, earnings multiples are highly attractive compared with competitors.
- The stock, which is currently worth 2024 to 0.42 times its sales, is clearly overvalued in comparison with peers.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company sustains low margins.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- Revenue estimates are regularly revised downwards for the current and coming years.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last few months, analysts have been revising downwards their earnings forecast.
- Over the past four months, analysts' average price target has been revised downwards significantly.
Ratings chart - Surperformance
Sector: Personal Products
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-.--% | 546M | - | ||
+12.74% | 390B | C- | ||
+13.92% | 138B | B- | ||
+21.75% | 79.62B | A+ | ||
-4.36% | 71.68B | A- | ||
-27.28% | 38.13B | B+ | ||
-14.96% | 35.06B | - | ||
+0.41% | 33.01B | B- | ||
+9.36% | 18.3B | A- | ||
+21.45% | 16.83B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- NUS Stock
- NUS Stock
- Ratings Nu Skin Enterprises, Inc.